Impact of Antibiotics on Human Microbiota and Resistance Development
Center of Medicine · 24.07.2026 · 2 (3) · 107-124
DOI: 10.65591/com-77-2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Center of Medicine, online erschienen am 24.07.2026. Verfasst von Zakeeyah Saliam Mohammed Qajjam und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This bibliometric study examines the development, knowledge structure, and emerging directions of artificial intelligence (AI), machine learning (ML), and deep learning (DL) research related to irritable bowel syndrome (IBS), gut microbiota, and gastrointestinal disorders. Records were retrieved from the Science Citation Index Expanded (SCI-E) in the Web of Science Core Collection (WoSCC) on October 25, 2024. The corrected search strategy was reported transparently as: ALL=(("artificial intelligence" OR "machine learning" OR "deep learning" OR AI OR ML OR DL) AND ("irritable bowel syndrome" OR IBS)). English-language articles and reviews in the biological and medical sciences were screened independently by two reviewers. After removal of duplicates and irrelevant records, 21 articles published between 2011 and 2024 were retained. Bibliometric.com was used to visualize country collaboration, VOSviewer was used for keyword co-occurrence mapping, CiteSpace was used to examine temporal keyword trends, and Publish or Perish was used to summarize citation indicators. The final corpus included 21 WoS-indexed records covering 2011-2024. Publication output was sparse before 2020, increased sharply during 2020-2021, and then stabilized at four to five publications annually during 2022-2024. Keyword mapping showed that IBS was closely connected with patient-related terms, diagnosis, disease, machine learning, gut microbiome, prevalence, and symptoms. The geographic and institutional analyses indicated visible contributions from Japan, Iran, China, and the United Kingdom, while high-impact Q1 journals dominated the publication venues. However, because the dataset is small and limited to SCI-E/WoSCC, the results should be interpreted as a descriptive map of an emerging field rather than a definitive global estimate of AI-based IBS research. AI-based IBS research remains an early but clinically relevant field. The evidence suggests a gradual shift from descriptive microbiome profiling toward predictive diagnostic models, symptom stratification, and personalized interventions. Future studies should combine bibliometric mapping with systematic extraction of algorithm types, datasets, performance metrics, clinical validation, and real-world usefulness for clinicians, patients, and health-policy stakeholders.
Zitieren
APA
Qajjam, Z. S. M., & Saleh, E. E. (2026). Impact of Antibiotics on Human Microbiota and Resistance Development. Center of Medicine, 2(3), 107-124. https://doi.org/10.65591/com-77-2026
Vancouver
Qajjam ZSM, Saleh EE. Impact of Antibiotics on Human Microbiota and Resistance Development. Center of Medicine. 2026;2(3):107-124. doi:10.65591/com-77-2026
BibTeX
@article{Qajjam2026,
author = {Qajjam, Zakeeyah Saliam Mohammed and Saleh, Esraa Elsayed},
title = {Impact of Antibiotics on Human Microbiota and Resistance Development},
journal = {Center of Medicine},
year = {2026},
volume = {2},
number = {3},
pages = {107--124},
doi = {10.65591/com-77-2026}
}
EUVIMED